Kalen Biomedical LLC

Sequella Inc. is a clinical-stage pharmaceutical company based in Rockville, MD, focused on developing innovative antibiotics to combat drug-resistant bacterial, fungal, and parasitic infections. Their product pipeline addresses significant global health threats, particularly tuberculosis and its multidrug-resistant forms, which impact billions of people worldwide. With two drug candidates having completed phase 2 clinical trials and additional candidates in preclinical development, Sequella aims to tackle various infectious diseases, including Helicobacter pylori infections and Clostridium difficile. Their research also explores treatments for non-tuberculous mycobacterial infections and parasitic diseases, demonstrating a commitment to addressing critical health challenges globally. Generated from the website

MolBox LLC, located in Silver Spring, MD, specializes in consulting services and custom software solutions tailored for the fields of bioinformatics and molecular modeling. The company is dedicated to enhancing high-performance computing, data visualization, and laboratory automation for its clients. By integrating advanced technological solutions, MolBox LLC supports scientific innovation and research efficiency. Their comprehensive offerings position them as a valuable partner for organizations seeking to optimize their data management and computational tasks. Generated from the website

Medimmune, located in Gaithersburg, MD, is a leading biopharmaceutical company specializing in the research and production of biologic medications for disease prevention and treatment. The company is dedicated to developing innovative solutions that aim to improve public health and advance scientific knowledge in the field of biotechnology. Generated from their available business information